Abstract
The clinicopathological characteristics and prognosis of gastric mucinous adenocarcinoma (MAC) and signet ring cell carcinoma (SRC) are still controversial. We designed our study to evaluate the clinicopathologic features and prognosis of MAC, SRC and ordinary gastric adenocarcinoma (OGAC) by analyzing the Surveillance, Epidemiology, and End Results (SEER)-registered database. The 5-year overall survival (OS) of patients with SRC was significantly lower than that of patients with MAC (P = 0.001) and OGAC (P < 0.001), and there was no significant difference in 5-year OS between MAC and OGAC (P = 0.804). Furthermore, there were no significant differences of 5-years OS among these three groups at stage I, II and III (all P > 0.05) and no significant difference between MAC and OGAC at stage IV (P = 0.110). Patients in SRC group had significantly worse survival than those in MAC and OGAC at stage IV (both P = 0.008), with 5-year OS of 3.3%, 5.8%, and 5.8%, respectively. However, the histological type was not found to be an independent prognostic factor of gastric cancer according to the multivariate analysis with Cox regression.
Similar content being viewed by others
References
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108
Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(8):S4–66
Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of Tumours of the digestive system, fourth edition. Int Agency Res Cancer 3:1089
Lauren P (1965) The two main histological types of gastric carcinoma: diffuse and so called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49
Ribeiro MM, Sarmento JA, Simos SMA, Bastos J (1981) Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma. Cancer 47:780–784
Ming SC (1977) Gastric carcinoma: a pathological classification. Cancer 39(6):2475–2485
Sugano H, Nakamura K, Kato Y (1982) Pathological studies of human gastric cancers. Acta Pathol Jpn 32:329–347
Kawamura H, Kondo Y, Osawa S, Nisida Y, Okada K, Isizu H, Uebayasi T, Takahasi M, Hata T (2001) A clinicopathologic study of mucinous adenocarcinoma of the stomach. Gastric Cancer 4:83–86
Wu CY, Yeh HZ, Shih RT, Chen GH (1998) A clinicopathologic study of mucinous gastric carcinoma including multivariate analysis. Cancer 83:1312–1318
Hoerr SO, Hazard JB, Bailey D (1966) Prognosis in carcinoma of the stomach in relation to the microscopic type. Surg Gynecol Obstet 122:485–494
Adachi Y, Yasuda K, Inomata M, Shiraishi N, Kitano S, Sugimachi K (2001) Clinicopathologic study of early-stage mucinous gastric carcinoma. Cancer 91:698–703
Isobe T, Hashimoto K, Kizaki J, Matono S, Murakami N, Kinugasa T, Aoyagi K, Akagi Y (2015) Characteristics and prognosis of mucinous gastric carcinoma. Mol Clin Oncol 3(1):44–50
Yin C, Li D, Sun Z, Zhang T, Xu Y, Wang Z, Xu H (2012) Clinicopathologic features and prognosis analysis of mucinous gastric carcinoma. Med Oncol 29(2):864–870
Otsuji E, Yamaguchi Y, Sawai K, Takahashi T (1998) Characterization of signet ring cell carcinoma of the stomach. J Surg Oncol 67:216–220
Hyung WJ, Noh SH, Lee JH, Huh JJ, Lah KH, Choi SH, Min JS (2002) Early gastric carcinoma with signet ring cell histology. Cancer 94:78–83
Jiang CG, Wang ZN, Sun Z, Liu FN, Yu M, Xu HM (2011) Clinicopathologic characteristics and prognosis of signet ring cell carcinoma of the stomach: results from a Chinese mono-institutional study. J Surg Oncol 103(7):700–703
Maehara Y, Sakaguchi Y, Moriguchi S, Orita H, Korenaga D, Kohnoe S, Sugimachi K (1992) Signet ring cell carcinoma of the stomach. Cancer 69:1645–1650
Gronnier C, Messager M, Robb WB, Thiebot T, Louis D, Luc G, Piessen G, Mariette C (2013) Is the negative prognostic impact of signet ring cell histology maintained in early gastric adenocarcinoma. Surgery 154(5):1093–1099
Chiu CT, Kuo CJ, Yeh TS, Hsu JT, Liu KH, Yeh CN, Hwang TL, Jan YY, Lin CJ (2011) Early signet ring cell gastric cancer. Dig Dis Sci 56:1749–1756
Zhang M, Zhu G, Zhang H, Gao H, Xue Y (2010) Clinicopathologic features of gastric carcinoma with signet ring cell histology. J Gastrointest Surg 14(4):601–606
Piessen G, Messager M, Leteurtre E, Jean-Pierre T, Mariette C (2009) Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg 250(6):878–887
Yang XF, Yang L, Mao XY, Wu DY, Zhang SM, Xin Y (2004) Pathobiological behavior and molecular mechanism of signet ring cell carcinoma and mucinous adenocarcinoma of the stomach: a comparative study. World J Gastroenterol 10(5):750–754
Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, Shimada H (2006) Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma. Ann Surg Oncol 13:836–842
Zhang M, Zhu GY, Zhang HF, Gao HY, Han XF, Xue YW (2010) Clinicopathologic characteristics and prognosis of mucinous gastric carcinoma. J Surg Oncol 102:64–67
Adachi Y, Mori M, Kido A, Shimono R, Maehara Y, Sugimachi K (1992) A clinicopathologic study of mucinous gastric carcinoma. Cancer 69:866–871
Antonioli DA, Goldman H (1982) Changes in the location and type of gastric carcinoma. Cancer 50:775–781
Theuer CP, Nastansk F, Brewster WR, Butler JA, Anton-Culver H (1999) Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival. Am Surg 65:915–921
Kim JP, Kim SC, Yang HK (1994) Prognostic significance of signet ring cell carcinoma of the stomach. Surg Oncol 50:775–781
Ryu SY, Kim HG, Lee JH, Kim DY (2014) Prognosis of early mucinous gastric carcinoma. Ann Surg Treat Res 87(1):5–8
Matsuyama S, Ohkura Y, Eguchi H, Kobayashi Y, Akagi K, Uchida K, Nakachi K, Gustafsson JA, Hayashi S (2002) Estrogen receptor beta is expressed in human stomach adenocarcinoma. J Cancer Res Clin Oncol 128(6):319–324
Kitaoka H (1983) Sex hormone dependency and endocrine therapy in diffuse carcinoma of the stomach. Gan To Kagaku Ryoho 10(12):2453–2460
Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Akiyama H (2004) Therapeutic strategy for signet ring cell carcinoma of the stomach. Br J Surg 91(10):1319–1324
Ha TK, An JY, Youn HK, Noh JH, Sohn TS, Kim S (2008) Indication for endoscopic mucosal resection in early signet ring cell gastric cancer. Ann Surg Oncol 15(2):508–513
Lee JH, Choi IJ, Kook MC, Nam BH, Kim YW, Ryu KW (2010) Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology. Br J Surg 97(5):732–736
Li C, Kim S, Lai JF, Hyung WJ, Choi WH, Choi SH, Noh SH (2007) Advanced gastric carcinoma with signet ring cell histology. Oncology 72(1–2):64–68
Kwon KJ, Shim KN, Song EM, Choi JY, Kim SE, Jung HK, Jung SA (2014) Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach. Gastric Cancer 17(1):43–53
Kim DY, Park YK, Joo JK, Ryu SY, Kim YJ, Kim SK, Lee JH (2004) Clinicopathological characteristics of signet ring cell carcinoma of the stomach. ANZ J Surg 74(12):1060–1064
Acknowledgement
The authors acknowledge the efforts of the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in the creation of the SEER database. The interpretation and reporting of these data are the sole responsibility of the authors. The authors have no support or funding to report.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
KTL and JFW conceived of and designed the study. KTL, JFW and YPB performed the analyses. YPB and XC prepared all tables. KTL and MZL wrote the main manuscript. All authors reviewed the manuscript.
Compliance with Ethical Standards
ᅟ
Disclosure
The authors declare that they have no competing interests.
Additional information
Kaitai Liu and Juefeng Wan contributed equally to this work.
Rights and permissions
About this article
Cite this article
Liu, K., Wan, J., Bei, Y. et al. Prognostic Impact of Different Histological Types on Gastric Adenocarcinoma: a Surveillance, Epidemiology, and End Results Database Analysis. Pathol. Oncol. Res. 23, 881–887 (2017). https://doi.org/10.1007/s12253-017-0198-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-017-0198-2